Federica Giordano, PhD
Director of Clinical Operations, March Biosciences
Federica Giordano, PhD, scientist by training and the Director of Clinical Operations at March Biosciences. She leads the multicenter Phase 2 MB-105 (autologous CD5 CAR-T) program for T-cell malignancies, overseeing and supporting clinical development /operations across sites, logistics, and clinical vendors.